Jae Sang Lee

This inventor holds 14 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignees: Samsung Display Co., Ltd., Industry-University Cooperation Foundation Hanyang University, Inje University Industry-Academic Cooperation Foundation. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae Sang Lee. Retrieved from https://idiyas.com/inventor/jae-sang-lee-m018bs7v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 6)

% Patents Active = 85.7

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Seoul, KR (2015)
Cheonan-si, KR (2014 - 2017)
Asan-si, KR (2016 - 2017)
Chungcheongnam-do, KR (2017)
Ansan-si, KR (2020 - 2024)

Company Filing History:

8 out of 27,288

Samsung Display Co., Ltd.

patents

7 out of 1,248

Industry-University Cooperation Foundation Hanyang University

patents

2 out of 69

Inje University Industry-Academic Cooperation Foundation

patents

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12049491 - Multiblock copolypeptides of elastin-based polypeptides and mussel foot proteins with stimuli-responsiveness and surface-adhesive, methods of preparing thereof and use thereof (2024-07-30),

2. 11866470 - Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses (2024-01-09),

3. 11827679 - Self-assembled nanostructures of elastin- and resilin-based block copolypeptides with stimuli responsiveness and resilience for drug delivery system, tissue engineering and regenerative medicine and methods of preparing the same (2023-11-28),

4. 11518798 - Vascular endothelial growth factor receptor targeting peptide-elastin fusion polypeptides (2022-12-06),

5. 11059870 - Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses (2021-07-13),

6. 10662236 - Vascular endothelial growth factor receptor targeting peptide-elastin fusion polypeptides (2020-05-26),

7. 9810934 - Display device (2017-11-07),

8. 9746602 - Backlight device and display device including the same (2017-08-29),

9. 9618023 - Display device and fixing element for use in the display device (2017-04-11),

10. 9575361 - Reflection sheet and backlight unit including the same (2017-02-21),

11. 9541702 - Display device (2017-01-10),

12. 9383605 - Backlight unit and liquid crystal display including the same (2016-07-05),

13. 9111789 - Thin film transistor array panel (2015-08-18),

14. 8752998 - Display device (2014-06-17),

Title: Inventor Jae Sang Lee: Revolutionizing Technology in Asan-si, KR

Introduction: Jae Sang Lee is a visionary inventor based in Asan-si, South Korea, known for his groundbreaking contributions to the field of technology.

Latest Patents: Lee holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Jae Sang Lee has worked with top research institutions and leading tech companies to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Lee has collaborated with renowned scientists, engineers, and inventors from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion: Inventor Jae Sang Lee's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and shape the future of technological advancements.

Profile summary based on public USPTO records.